Cargando…

A Real-World Experience from a Single Center (LPCE, Nice, France) Highlights the Urgent Need to Abandon Immunohistochemistry for ROS1 Rearrangement Screening of Advanced Non-Squamous Non-Small Cell Lung Cancer

The detection of ROS1 rearrangements in metastatic non-squamous non-small cell lung carcinoma (NS-NSCLC) permits administration of efficient targeted therapy. Detection is based on a testing algorithm associated with ROS1 immunohistochemistry (IHC) screening followed by ROS1 FISH and/or next generat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hofman, Véronique, Goffinet, Samantha, Bontoux, Christophe, Long-Mira, Elodie, Lassalle, Sandra, Ilié, Marius, Hofman, Paul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10222775/ https://www.ncbi.nlm.nih.gov/pubmed/37240980 http://dx.doi.org/10.3390/jpm13050810

Ejemplares similares

Setting Up an Ultra-Fast Next-Generation Sequencing Approach as Reflex Testing at Diagnosis of Non-Squamous Non-Small Cell Lung Cancer; Experience of a Single Center (LPCE, Nice, France)
por: Ilié, Marius, et al.
Publicado: (2022)

Targeted Assessment of the EGFR Status as Reflex Testing in Treatment-Naive Non-Squamous Cell Lung Carcinoma Patients: A Single Laboratory Experience (LPCE, Nice, France)
por: Lassalle, Sandra, et al.
Publicado: (2020)

Setting-Up a Rapid SARS-CoV-2 Genome Assessment by Next-Generation Sequencing in an Academic Hospital Center (LPCE, Louis Pasteur Hospital, Nice, France)
por: Hofman, Paul, et al.
Publicado: (2022)

Any Place for Immunohistochemistry within the Predictive Biomarkers of Treatment in Lung Cancer Patients?
por: Hofman, Véronique, et al.
Publicado: (2018)

Multiplexed Immunohistochemistry for Molecular and Immune Profiling in Lung Cancer—Just About Ready for Prime-Time?
por: Hofman, Paul, et al.
Publicado: (2019)

The Need to Set up a Biobank Dedicated to Lymphoid Malignancies: Experience of a Single Center (Laboratory of Clinical and Experimental Pathology, University Côte d’Azur, Nice, France)
por: Bontoux, Christophe, et al.
Publicado: (2023)

The Third Joint Meeting on Lung Cancer of the FHU OncoAge (University Côte d’Azur, Nice, France) and the University of Texas MD Anderson Cancer Center (Houston, TX, USA). Understanding New Therapeutic Options and Promising Predictive Biomarkers for Lung Cancer Patients
por: Hofman, Paul, et al.
Publicado: (2022)

Molecular Profiling in Non-Squamous Non-Small Cell Lung Carcinoma: Towards a Switch to Next-Generation Sequencing Reflex Testing
por: Pujol, Nina, et al.
Publicado: (2022)

Screening of ROS1 Rearrangements in Lung Adenocarcinoma by Immunohistochemistry and Comparison with ALK Rearrangements
por: Cha, Yoon Jin, et al.
Publicado: (2014)

Chromogenic Multiplex Immunohistochemistry Reveals Modulation of the Immune Microenvironment Associated with Survival in Elderly Patients with Lung Adenocarcinoma
por: Ilié, Marius, et al.
Publicado: (2018)

Establishing a Dedicated Lung Cancer Biobank at the University Center Hospital of Nice (France). Why and How?
por: Washetine, Kevin, et al.
Publicado: (2018)

Daily Practice Assessment of KRAS Status in NSCLC Patients: A New Challenge for the Thoracic Pathologist Is Right around the Corner
por: Bontoux, Christophe, et al.
Publicado: (2022)

Deciphering the Impact of HER2 Alterations on Non-Small-Cell Lung Cancer: From Biological Mechanisms to Therapeutic Approaches
por: Bontoux, Christophe, et al.
Publicado: (2022)

Immunohistochemistry for Diagnosis of Metastatic Carcinomas of Unknown Primary Site
por: Selves, Janick, et al.
Publicado: (2018)

Prognostic Role of KRAS G12C Mutation in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
por: Wankhede, Durgesh, et al.
Publicado: (2023)

Deep Learning Facilitates Distinguishing Histologic Subtypes of Pulmonary Neuroendocrine Tumors on Digital Whole-Slide Images
por: Ilié, Marius, et al.
Publicado: (2022)

Efficient Treatment of Rheumatoid Arthritis by Degradable LPCE Nano-Conjugate-Delivered p65 siRNA
por: Chen, Xiaohua, et al.
Publicado: (2022)

Identification of a circulating immunological signature predictive of response to immune checkpoint inhibitors in patients with advanced non‐small cell lung cancer
por: Khatir, Wassila, et al.
Publicado: (2022)

Use of the 22C3 anti–PD-L1 antibody to determine PD-L1 expression in multiple automated immunohistochemistry platforms
por: Ilie, Marius, et al.
Publicado: (2017)

Accurate Detection of SARS-CoV-2 by Next-Generation Sequencing in Low Viral Load Specimens
por: Ilié, Marius, et al.
Publicado: (2023)

Detection of EGFR Mutations From Plasma of NSCLC Patients Using an Automatic Cartridge-Based PCR System
por: Heeke, Simon, et al.
Publicado: (2021)

Correction: Use of the 22C3 anti-PD-L1 antibody to determine PD-L1 expression in multiple automated immunohistochemistry platforms
por: Ilie, Marius, et al.
Publicado: (2017)

Setting up a wide panel of patient-derived tumor xenografts of non–small cell lung cancer by improving the preanalytical steps
por: Ilie, Marius, et al.
Publicado: (2015)

ROS1 Immunohistochemistry Among Major Genotypes of Non—Small-Cell Lung Cancer
por: Boyle, Theresa A., et al.
Publicado: (2014)

Optimization of EGFR mutation detection by the fully-automated qPCR-based Idylla system on tumor tissue from patients with non-small cell lung cancer
por: Ilie, Marius, et al.
Publicado: (2017)

MYC Immunohistochemistry Predicts MYC Rearrangements by FISH
por: Nwanze, Julum, et al.
Publicado: (2017)

Neglect and abandonment of persons with dementia in India: Urgent need for residential and day-care facilities
por: Singh, Om Prakash
Publicado: (2019)

Comparison of Two Rapid Assays for the Detection of BRAF V600 Mutations in Metastatic Melanoma including Positive Sentinel Lymph Nodes
por: Long-Mira, Elodie, et al.
Publicado: (2022)

Entrectinib resistance mechanisms in ROS1-rearranged non-small cell lung cancer
por: Ku, Bo Mi, et al.
Publicado: (2019)

Crizotinib efficacy in advanced non-squamous NSCLC patients with ALK or ROS1 rearrangement
por: Krawczyk, Paweł, et al.
Publicado: (2021)

Therapeutical Options in ROS1—Rearranged Advanced Non Small Cell Lung Cancer
por: Stanzione, Brigida, et al.
Publicado: (2023)

Association of TRF2 expression and myeloid-derived suppressor cells infiltration with clinical outcome of patients with cutaneous melanoma
por: Ilié, Marius, et al.
Publicado: (2021)

Highlight: A Matter of Taste—Whales Have Abandoned Their Ability to Taste Food
por: Venton, Danielle
Publicado: (2014)

“Sentinel” Circulating Tumor Cells Allow Early Diagnosis of Lung Cancer in Patients with Chronic Obstructive Pulmonary Disease
por: Ilie, Marius, et al.
Publicado: (2014)

Need for a Dedicated Ophthalmic Malignancy Clinico-Biological Biobank: The Nice Ocular MAlignancy (NOMA) Biobank
por: Martel, Arnaud, et al.
Publicado: (2023)

Que reste t-il de la microscopie électronique pour le diagnostic anatomopathologique en 2010 ?
por: Mari, Mireille, et al.
Publicado: (2010)

Detection of ROS1 rearrangement in non-small cell lung cancer: current and future perspectives
por: Rossi, Giulio, et al.
Publicado: (2017)

ROS1 rearrangement and response to crizotinib in Stage IV non-small cell lung cancer
por: Suryavanshi, Moushumi, et al.
Publicado: (2017)

Weighty: NICE's Not-So-Nice Words
por: Lozano-Sufrategui, Lorena, et al.
Publicado: (2016)

Reply 1: Call for NICE to review urgently their guidance concerning first-line chemotherapy for metastatic colorectal cancer
por: Saunders, M P, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_a4mq8bn0q4lmtdijftqnleghgi